ClinicalTrials.gg
Sign In

Biological

Autologous Tumor Infiltrating Lymphocytes LN-145-S1 clinical trials

studies test it
3
open now
0
in phase 3
0
first study started
2017

How studies write it

Studies that test it under each name

Name

LN-145-S1
3
Autologous Tumor Infiltrating Lymphocytes LN-145-S1
1

Studies by the year they started

3 studies that test it; most in 2017 (1)

Studies that test Autologous Tumor Infiltrating Lymphocytes LN-145-S1, by start year
YearStudies
20171
20181
20191

By phase

A phase 1/2 study counts in both.

Phase 2
3

What it is tested for

Each study’s main condition, where its own words name it.

Squamous Cell Carcinoma of Head and Neck
1
Melanoma
1

Who runs them

Industry 2 · Other 1

Iovance Biotherapeutics, Inc. (2) · M.D. Anderson Cancer Center (1)

Often tested with

Tested in the same studies.

Lifileucel (2) · Autologous Tumor Infiltrating Lymphocytes LN-145 (2)

Studies

Open first, then newest update. How each study uses Autologous Tumor Infiltrating Lymphocytes LN-145-S1 is read from its arms, and is right about nine times in ten.

Testing it · 3